Neoplasm clinical trials
21 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
- Feasibility of Remote Activity Assessment and PRO Collection Among Transgender Cancer Survivors
- Sample Collection and Tracking for the Developmental Therapeutics Clinic
- The Radiation Oncology Registry and Biosample Repository
- Registry Study for Radiation Therapy Outcomes
- Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
- Clinical and Genetic Studies of Li-Fraumeni Syndrome
- Collection of Tissue Samples for Cancer Research
- 100-Year Human Aging Study
- Human Observatory Study
- AnovaOS Network Powered Patient Registry
- AIMS Medical Outcomes Study
- RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
- The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
- A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer
- Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Implementing VTE Prevention in Ambulatory Cancer Care
- Data Collection of Standard Care and Evaluation of NHLBI Patients and Donors
- Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
- Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Neoplasm” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.